Mrozikiewicz-Rakowska, B.; Szabłowska-Gadomska, I.; Cysewski, D.; Rudziński, S.; Płoski, R.; Gasperowicz, P.; Konarzewska, M.; Zieliński, J.; Mieczkowski, M.; Sieńko, D.;
et al. Allogenic Adipose-Derived Stem Cells in Diabetic Foot Ulcer Treatment: Clinical Effectiveness, Safety, Survival in the Wound Site, and Proteomic Impact. Int. J. Mol. Sci. 2023, 24, 1472.
https://doi.org/10.3390/ijms24021472
AMA Style
Mrozikiewicz-Rakowska B, Szabłowska-Gadomska I, Cysewski D, Rudziński S, Płoski R, Gasperowicz P, Konarzewska M, Zieliński J, Mieczkowski M, Sieńko D,
et al. Allogenic Adipose-Derived Stem Cells in Diabetic Foot Ulcer Treatment: Clinical Effectiveness, Safety, Survival in the Wound Site, and Proteomic Impact. International Journal of Molecular Sciences. 2023; 24(2):1472.
https://doi.org/10.3390/ijms24021472
Chicago/Turabian Style
Mrozikiewicz-Rakowska, Beata, Ilona Szabłowska-Gadomska, Dominik Cysewski, Stefan Rudziński, Rafał Płoski, Piotr Gasperowicz, Magdalena Konarzewska, Jakub Zieliński, Mateusz Mieczkowski, Damian Sieńko,
and et al. 2023. "Allogenic Adipose-Derived Stem Cells in Diabetic Foot Ulcer Treatment: Clinical Effectiveness, Safety, Survival in the Wound Site, and Proteomic Impact" International Journal of Molecular Sciences 24, no. 2: 1472.
https://doi.org/10.3390/ijms24021472
APA Style
Mrozikiewicz-Rakowska, B., Szabłowska-Gadomska, I., Cysewski, D., Rudziński, S., Płoski, R., Gasperowicz, P., Konarzewska, M., Zieliński, J., Mieczkowski, M., Sieńko, D., Grzela, T., Noszczyk, M., Paleska, B., Czupryniak, L., & Lewandowska-Szumiel, M.
(2023). Allogenic Adipose-Derived Stem Cells in Diabetic Foot Ulcer Treatment: Clinical Effectiveness, Safety, Survival in the Wound Site, and Proteomic Impact. International Journal of Molecular Sciences, 24(2), 1472.
https://doi.org/10.3390/ijms24021472